The Gynaeoncology Clinic provides assessment, diagnosis, multidisciplinary care team planning and surgical management of known or suspected gynaecological cancer or precancerous conditions. We also provide ovarian risk-reducing surgery for women at high risk.
Services available
- Surgical management for precancerous and cancerous gynaecological conditions
- Multidisciplinary meetings – coordination with Peter MacCallum (provide chemotherapy/radiotherapy if needed) and Royal Melbourne Hospital (provide specialties such as urology or colorectal)
- Ovarian cancer risk reduction bilateral salpingo-oopherectomy surgery
- Gestational trophoblastic disease (hydatidiform mole)
Inclusion criteria
- Cervix: Lesion suspicious of cancer on cervix or vagina on speculum examination
- Uterine: Confirmed diagnosis of endometrial cancer or atypical hyperplasia of the endometrium
- Vulva: Biopsy-proven cancer of the vulva
- Ovary: Suspicious pelvic mass on ultrasound scan, ascites, elevated CA 125 (Normal range: 2–35)
- Other: Increased genetic risk of gynaecological malignancy and considering risk-reduction surgery
Patients who present with symptoms suspicious of gynaecological malignancy should be referred to a specialist gynaeoncology service: the Women’s, Monash Health, Western Health or Mercy Health.
Refer to the Women's Gynaeoncology Clinic if it is the patient's closest specialist gynaeoncology service.
Urgent referral
Mark your referral urgent if the patient has any of the following:
- Concerns of malignancy (clinically, imaging or tumour markers)
- Abnormal appearance of the cervix, vagina or vulva on examination including unexplained vulval lump or ulceration
- Postmenopausal bleeding on Tamoxifen or thickened endometrium
- Abnormal bleeding and is taking Tamoxifen
- Persistent intermenstrual bleeding and aged >40, or with risk factors for endometrial cancer
For assessment or care due to concerning or deteriorating condition, please call Gynaeoncology Fellow via the Women’s switchboard on (03) 8345 2000.
Exclusion criteria
Benign conditions better cared for by general gynaecology (referrals will be triaged to the most suitable clinic).
Referral instructions
Essential information
All referrals must include essential demographic, medical and social history details, and relevant information about the presenting complaint.
In detail: Women's health referrals
Investigations
- Findings of abdominal/pelvic examination and/or speculum examination of the cervix
- Pelvic ultrasound
- Most recent CST*
- Consider: STI screen
*In patients with clinical features that raise the suspicion of cervical cancer found on examination of the cervix, mark your referral urgent. A CST is not required before urgent referral. A previous negative cervical screen result is not a reason to delay referral.
For patients with a known genetic abnormality that puts them at increased risk of gynaecological malignancy, and who are considering risk-reduction surgery, please provide:
- Genetic test result
- If available: recent pelvic ultrasound
Send referral
GPs, specialists and nurse practitioners can refer directly to the Gynaeoncology Clinic via Fast Fax: (03) 8345 3036.
Use our Women’s Health Referral Form – jump to Referral templates (Downloads).
In detail: How referrals are processed
Appointments
- Gynaeoncology and pre-admission clinics: Monday mornings and Tuesday afternoons
- Post-op clinic: Alternate Monday afternoons
- Risk reduction clinic: Alternate Wednesday afternoons
Most clinics have both face-to-face and telehealth options.
Related information
- Referral forms and information
- Optimal care pathway for women with cervical cancer (PDF) Quick reference guide, Cancer Council, Jan 2020
- Optimal care pathway for women with ovarian cancer (PDF) Quick reference guide, Cancer Council, June 2021
- Cancer Council Victoria
- Counterpart (was BreCan) Information and support for people affected by a gynaecological or breast cancer, their families and friends.
- Multilingual Cancer Information Line
- Find a health information fact sheet for your patient
Downloads and Related Topics
Date reviewed: 15 January 2025
Date reviewed: 15 January 2025